SCHEMBL3535643

SCHEMBL3535643

S=C1CC=CC=C1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11600094 0.72
SCHEMBL9711600 0.70
SCHEMBL356893 0.70
SCHEMBL1037721 0.69
SCHEMBL3980860 0.69
SCHEMBL162495 0.68
SCHEMBL1983188 0.68
SCHEMBL1536249 0.68
SCHEMBL1088381 0.68
SCHEMBL3277518 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7829566-B2 Such as (7-chloro-2-styryl-quinazolin-4-yl)-(3-imidazol-1-yl-propyl)-amine; glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents MEDERSKI WERNER 2010-11-09 US disclosed
US-7547702-B2 4-amino-quinazolines ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2009-06-16 US disclosed
US-20070293667-A1 4-Amino-quinazolines MEDERSKI WERNER 2007-12-20 US disclosed
US-7060706-B1 Quinazolinones 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2006-06-13 US disclosed
US-20060019974-A1 Glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents ORTHO-MCNEIL PHARMACEUTICALS, INC. 2006-01-26 US disclosed
US-6890930-B1 Quinazolinones 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2005-05-10 US disclosed
WO-2004030672-A1 USE OF 4 AMINO-QUINAZOLINES AS ANTI CANCER AGENTS MERCK PATENT GMBH (DE) 2004-04-15 WO disclosed
WO-2004030671-A2 USE OF 4-AMINO-QUINAZOLINES AS ANTI CANCER AGENTS MERCK PATENT GMBH (DE) 2004-04-15 WO disclosed
US-20040044204-A1 4-amino-quinazolines ORTHO-MCNEIL PHARMACEUTICALS, INC. 2004-03-04 US disclosed
EP-1318984-A1 4-AMINO-QUINAZOLINES MERCK PATENT GmbH (DE) 2003-06-18 EP disclosed
WO-2001023365-A1 QUINAZOLINONES MERCK PATENT GMBH (DE) 2001-04-05 WO disclosed
WO-2001023364-A1 QUINAZOLINONES MERCK PATENT GMBH (DE) 2001-04-05 WO disclosed
US-6180645-B1 ANTIEPILEPIC AGENT BOEHRINGER INGELHEIM GMBH (DE) 2001-01-30 US disclosed
EP-0736012-B1 ANELLATED DIHYDROPYRIDINES AND THEIR USE IN THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS BOEHRINGER INGELHEIM PHARMA (DE) 2000-11-22 EP disclosed
US-5925650-A PROTECTION AGAINST STROKE IN MAMMALS BOEHRINGER INGELHEIM KG (DE) 1999-07-20 US disclosed
US-5837712-A PREVENTION OF STROKE BOEHRINGER INGELHEIM KG (DE) 1998-11-17 US disclosed
CN-1181379-A Process for preparation of 3 -piperazinylbenzisothiazoles SUMITOMO SEIKA CHEMICALS (JP) 1998-05-13 CN disclosed
US-5607943-A CARDIOPROTECTIVE, CEREBROPROTECTIVE, ANTIINFLAMMATORY AGENTS BOEHRINGER INGELHEIM GMBH (DE) 1997-03-04 US disclosed
EP-0736012-A1 ANELLATED DIHYDROPYRIDINES AND THEIR USE IN THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS BOEHRINGER INGELHEIM KG (DE) 1996-10-09 EP disclosed
WO-1995017388-A1 ANELLATED DIHYDROPYRIDINES AND THEIR USE IN THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS BOEHRINGER INGELHEIM KG (DE) 1995-06-29 WO disclosed